Sensei Biotherapeutics Inc at Jefferies Healthcare Conference Transcript
Hello, everyone. Can everyone hear okay? I'm Russell Rudd from Jefferies healthcare banking. It's my pleasure to introduce CEO of Sensei, John Celebi. And I'll let you take it away.
Thanks very much, Russell, and thank you to the Jefferies team for inviting us to present at their wonderful conference. As you can probably tell from our title slide, Sensei is an immuno-oncology company. The words conditionally active are something we're going to spend a little bit of time on this morning explaining to you how our conditionally active biologics work. There are forward looking statements in this presentation.
Just to give you a little bit of background information on the company, Sensei is really focused on solving one of the key challenges in the industry today, and that is the development of therapeutics for immuno-oncology that are more finely tuned to be active within the tumor microenvironment. And the goal of that is to create better therapeutic windows
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |